An in vivo and in vitro 1H-magnetic resonance spectroscopy study of mdx mouse brain: Abnormal development or neural necrosis?

Journal of the Neurological Sciences

Volumn 141, Issue 1-2, 1996, Pages 13-18

  Tracey, I ^a,b   Dunn, J F ^a   Parkes, H G ^a,c   Radda, G K ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b RADCLIFFE INFIRMARY   (United Kingdom)

^c UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

1H MRS; Brain; Choline; Dystrophy deficiency; mdx; N acetyl aspartate

Indexed keywords

CHOLINE; CREATINE; INOSITOL; N ACETYLASPARTIC ACID; ASPARTIC ACID; DRUG DERIVATIVE; DYSTROPHIN; N-ACETYLASPARTATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; GENE EXPRESSION; GLIOSIS; MOUSE; MUSCULAR DYSTROPHY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; ANIMAL; ASTROCYTE; BRAIN; BRAIN LEVEL; C57BL MOUSE; CHEMISTRY; CONGENITAL MALFORMATION; FEMALE; MALE; METABOLISM; NECROSIS; NERVE CELL; PATHOLOGY; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE;

ANIMALS; ASPARTIC ACID; ASTROCYTES; BRAIN; BRAIN CHEMISTRY; CHOLINE; CREATINE; DYSTROPHIN; FEMALE; GLIOSIS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED MDX; NECROSIS; NEURONS;

EID: 0030586992     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0022-510X(96)00135-9     Document Type: Article

References (48)

1. Arnold, D.L., P.M. Matthews, G. Francis, J. Antel (1990) Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis: assessment of the load of disease. Magn. Reson. Med., 14: 154-159.
2. Barker, P.B, A.N. Breiter, B.J. Sober, et al. (1994) Quantitative Proton Spectroscopy of Canine Brain: in vivo and in vitro correlations. MRM, 32: 157-163.
3. Blake, D.J., J.M. Tinsley, K.E. Davies (1994) The emerging family of dystrophin-related proteins. Trends Cell Biol., 4: 19-23.
4. Bruhn, H., B. Kruse, G.C. Korenke, et al. (1992) Proton NMR spectroscopy of cerebral metabolic alterations in infantile peroxisomal disorders. J. Comput. Assist. Tomogr., 16: 335-344.
5. Bullfield, G., W.G. Siller, P.A.L. Wight, K.J. Moore (1984) X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc. Natl. Acad. Sci. USA, 81: 1189-1192.
6. 1H NMR detection of cerebral myo-inositol. FEBS Lett., 187: 167-172.
7. Chamberlain, J.S., J.A. Pearlman, D.M. Muzny, R.A. Gibbs, J.E. Rainer, A.A. Reeves et al. (1988) Expression of the murine Duchenne muscular dystrophy gene in muscle and brain. Science, 239: 1416-1418.
8. Charles, H.C., F. Lazeyras, R.K.K. Krishnan, O. Boyko, M. Payne, D. Moore (1992) Brain choline in depression: in vivo detection of potential pharmacodynamic effects of antidepressant therapy using hydrogen localised spectroscopy. Proc. 11th Ann. Meeting Soc. Mag. Reson. Med., p. 757.
9. Chelly, J., G. Hamard, A. Koulakoff, J.C. Kaplan, A., Y. Berwald-Netter (1990) Dystrophin gene transcribed from different promoters in neuronal and glial cells. Nature, 344: 64-65.
10. Clerk, A., F. Muntoni, P.N. Strong (1993) A dystrophin-immunoreactive protein in mammalian brain. J. Neurochem., 60: 435-441.
11. Conn, Jr. R.B (1960) Fluorimetric determination of creatine. Clin. Chem., 6: 537-548.
12. De Stefano, N., P.M. Matthews, D.L. Arnold (1995) Reversible Decreases in N-Acetylaspartate after acute brain injury. Magn. Reson. Med., 34: 721-727.
13. Dubowitz, V. and L. Crome (1969) The central nervous system in Duchenne muscular dystrophy. Brain, 92: 805-808.
14. Duchenne, G.B.A. (1861) Recherches sur la paralysie musculaire pseudo-hypertrophique ou paralysie myo-sclérosique. Arch. Gén. Méd., 11: 5-25, 179-209, 305-321, 421-443, 552-588.
15. Dunn, J.F., S. Frostick, G. Brown, G.K. Radda (1991) Energy status of cells lacking dystrophin: an in vivo/in vitro study of mdx mouse skeletal muscle. Biochim. Biophys. Acta, 1096: 115-120.
16. 31P-nuclear magnetic resonance study of mdx mice. Proc. R. Soc. Lond. B. Biol. Sci., 251: 201-206.
17. Feener, C.A., M. Koenig, L.M. Kunkel (1989) Alternative splicing of human dystrophinmRNA generates isoforms at the carboxy terminus. Nature, 338: 509-511.
18. Graham, G.D., A.M. Blamire, A.M. Howseman, et al. (1992) Proton magnetic resonance spectroscopy of cerebral lactate and other metabolites in stroke patients. Stroke, 23: 333-340.
19. 1H Nuclear Magnetic Resonance Spectroscopic imaging of neuronal loss in rat brain. Neuroscience, (in press).
20. Haws, C.M. and J.B. Lansman (1991) Calcium-permeable ion channels in cerebellar neurons from mdx mice. Proc. R. Soc. Lond. B. Biol. Sci., 244: 185-189.
21. Hodgson, S.V., S. Abbs, S. Clark, et al. (1992) Correlation of clinical and deletion data in Duchenne and Becker muscular dystrophy, with special reference to mental ability. Neuromuscular Disord., 2: 269-76.
22. Hoffman, E.P., R.H. Brown, Jr., L.M. Kunkel (1987) Dystrophin: the protein product of the DMD locus. Cell, 51: 919-928.
23. Hoffman, E.P., M. Hudecki, P. Rosenberg, C. Pollina, L.M. Kunkel (1988) Cell and fibre type distribution of dystrophin. Neuron, 1: 411-420.
24. Hopf, F.W., R.A. Steinhardt (1992) Regulation of intracellular free calcium in normal and dystrophic mouse cerebellar neurons. Brain Res., 578(1-2): 49-54.
25. Hore, P.J. (1983) A new method for water resonance suppression in the proton NMR spectra of aqueous solutions. J. Magn. Res., 54: 539-542.
26. Huard, J., P.Y. Cote, A. Parent, J.P. Bouchard, J.P. Tremblay (1992) Dystrophin-like immunoreactivity in monkey and human brain areas involved in learning and motor functions. Neurosci. Lett., 141: 181-186.
27. Jagadha, V. and L.E. Becker (1988) Brain morphology in Duchenne muscular dystrophy: a golgi study. Pediatr. Neurol., 4: 87-92.
28. 1-NMR spectroscopy in congenital myopathy. [abstract] Society Magnetic Resonance, Third Annual Meeting, Vol. 3, p. 1842.
29. Karagan, N.J. (1979) Intellectual functioning in Duchenne muscular dystrophy: a review. Psychol. Bull. 86: 250-259.
30. Kemp, G.J., D.J. Taylor, J.F. Dunn, S.P. Frostick, G.K. Radda (1993) Cellular energetics of dystrophic muscle. J. Neurol. Sci., 116: 201-206.
31. Kim, T.W., K. Wu, I.B. Black (1995) Deficiency of Brain Synaptic Dystrophin in Human Duchenne Muscular Dystrophy. Ann. Neurol., 38: 446-449.
32. Kreis, R., T. Ernst, B.D. Ross (1993) Development of the human brain: in vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy. Magn. Reson. Med., 30: 424-437.
33. Leibowitz, D. and V. Dubowitz (1981) Intellect and behaviour in Duchenne muscular dystrophy. Dev. Med. Child Neurol., 23: 577-590.
34. Matthews, P.M., F. Andermann, K. Silver, G. Karpati, D.L. Arnold (1993) Proton MR spectroscopy characterization of differences in regional brain matabolic abnormalities in mitochondrial encephalopathies. Neurology, 43: 2484-2490.
35. Mehler, M.F., K.Z. Haas, J.A. Kessler, P.K. Stanton (1992) Enhanced sensitivity of hippocampal pyramidal neurons from mdx mice to hypoxia-induced loss of synaptic transmission. Proc. Natl. Acad. Sci. USA, 89(6): 2461-2465.
36. Menon, D., C. Baudouin, D. Tomlinson, C. Hoyle (1990) Proton MR spectroscopy and imaging of the brain in AIDS: evidence of neuronal loss in regions that appear normal with imaging. J. Comput. Assist. Tomogr. 14: 882-885.
37. Monaco, A.P., R.L. Neve, C. Colletti-Feener, C.J. Bertelson, D.M. Kurnit, L.M. Kunkel (1986) Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene. Nature, 323: 646-650.
38. Muntoni, F., A. Mateddu, G. Serra (1991) Passive avoidance behaviour deficit in the mdx mouse. Neuromusc. Dis., 1: 121-123.
39. Nudel, U., K. Robzyk, D. Yaffe (1988) Expression of the putative Duchenne muscular dystrophy gene in differentiated myogenic cell cultures and in the brain. Nature, 331: 635-638.
40. Nudel, U., D. Zuk, P. Einat, et al. (1989) Duchenne muscular dystrophy gene product is not identical in muscle and brain. Nature, 337: 76-78.
41. 1H-MRS in Duchenne muscular dystrophy; metabolic and neuropsychological abnormalities. Society of Magnetic Resonance, Third Annual Meeting, Vol. 3, p. 1841.
42. 1H-NMR of acid extracts. Biochim. Biophys. Acta, 1054: 181-197.
43. Tallan, H. (1957) Studies on the distribution of N-acetyl-L-aspartic acid in brain. J. Biol. Chem., 224: 41-45.
44. Toft, P.B., H. Leth, H.C. Lou, O. Pryds, O. Henriksen (1994) Metabolite concentrations in the developing brain estimated with proton MR spectroscopy. J. Magn. Reson. Imag., 4: 674-680.
45. Tracey, I. (1993) Biochemical and Magnetic Resonance Studies of Animal Models of Human Disease. PhD Thesis, Oxford.
46. 31P-Magnetic Resonance Spectroscopy and Neuropyschological Study. Lancet, 345: 1260-64.
47. Tracey, I., J.F. Dunn, G.K. Radda (1996) Brain metabolism is abnormal in the mdx model of Duchenne Muscular Dystrophy. Brain, (in press).
48. Urenjak, J., S.R. Williams, D.G. Gadian, M. Noble (1992) Specific expression of N-acetyl aspartate in neurons, oligodendrocyte-type-2 astrocyte progenitors, and immature oligodendrocytes in vitro. J. Neurochem., 59(1): 55-61.